Refine by
Disease Modeling Suppliers In India
5 companies found
based inNavi Mumbai, INDIA
Yashraj Biotech Limited manufactures a wide range of high pure biomarkers in the form of native and recombinant proteins that are used by the diagnostic industry as controls, calibrators and immunogens. YBL has been the preferred partner of most of ...
Neural Progenitor Cells (NPCs) are multipotent cells derived from iPSCs that are self-renewing and have the potential to differentiate into various neuronal lineages. This makes them very attractive for in vitro patient-specific ...
based inAurora, ILLINOIS (USA)
Spectrum Technologies, Inc. was founded in 1987 and is headquartered in Aurora, Illinois. We manufacture and distribute affordable, leading-edge plant measurement technology to agricultural, horticultural, environmental and turf markets throughout ...
Become more proactive in your management of diseases and insects by adding forecast modules to your SpecConnect ...
based inBangalore, INDIA
Cellworks’ mission is to serve patients through advances in personalized medicine that significantly improve treatment success. We achieve better outcomes by predicting a successful match between patients and drug therapies – their Therapy Response ...
The Cellworks Platform biosimulates how a patient’s unique cancer will respond to therapies prior to treatment and identifies novel drug combinations for treatment-refractory patients. Therapy biosimulation is the ability to predict the ...
based inShelton, CONNECTICUT (USA)
PerkinElmer is passionate about providing customers with an unmatched experience as they help solve critical issues, especially impacting the diagnostics, discovery and analytical solutions markets. See how together we are improving lives and the ...
based inEschborn, GERMANY
When we looked at the decision making landscape in organizations and observed that the available technologies and models were helping make decisions but with fixed cycles of information processing, running in batches, with little flexibility and ...
Identify the biomarkers best suited for your needs: Diagnose rare or ambiguous diseases, Group patients by endotype response for prognosis, Assess disease etiology to determine responsive patient group ...